Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Atherosclerosis

• Publication date

  2007-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.ATHEROSCLEROSIS.2006.12.030PMID 17275828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synergistic roles of platelet-derived growth factor-BB and interleukin-1beta in phenotypic modulation of human aortic smooth muscle cells.

  2006cited by this paper
• Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells.

  2006cited by this paper
• Pleiotropic effects of statins.

  2005cited by this paper
• Urokinase‐induced signaling in human vascular smooth muscle cells is mediated by PDGFR‐β

  2005cited by this paper
• Rosuvastatin exerts favourable effects on thrombosis and neointimal growth in a mouse model of endothelial injury

  2004cited by this paper
• Global analysis of RNA expression profile in human vascular cells treated with statins.

  2004cited by this paper
• Inhibition of Geranylgeranylation Mediates the Effects of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Inhibitors on Microglia*

  2004cited by this paper
• Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions

  2004cited by this paper
• Beneficial Cardiovascular Pleiotropic Effects of Statins

  2004cited by this paper
• Fluvastatin Prevents Vascular Hyperplasia by Inhibiting Phenotype Modulation and Proliferation Through Extracellular Signal-Regulated Kinase 1 and 2 and p38 Mitogen-Activated Protein Kinase Inactivation in Organ-Cultured Artery

  2004cited by this paper
• Effects of Statins on Endothelium and Signaling Mechanisms

  2004cited by this paper
• uPA and uPAR in fibrinolysis, immunity and pathology.

  2004cited by this paper
• RHO SIGNALING in vascular diseases.

  2004cited by this paper
• Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway

  2003cited by this paper
• Rosuvastatin Reduces Atherosclerosis Development Beyond and Independent of Its Plasma Cholesterol–Lowering Effect in APOE*3-Leiden Transgenic Mice: Evidence for Antiinflammatory Effects of Rosuvastatin

  2003cited by this paper
• Mac-1 and Fas activities are concurrently required for execution of smooth muscle cell death by M-CSF-stimulated macrophages.

  2003cited by this paper
• Monocyte-expressed urokinase inhibits vascular smooth muscle cell growth by activating Stat1.

  2003cited by this paper
• Heterogeneity of Smooth Muscle Cell Populations Cultured From Pig Coronary Artery

  2002cited by this paper
• Gene Transfer of the Urokinase-Type Plasminogen Activator Receptor-Targeted Matrix Metalloproteinase Inhibitor TIMP-1.ATF Suppresses Neointima Formation More Efficiently Than Tissue Inhibitor of Metalloproteinase-1

  2002cited by this paper
• uPAR: a versatile signalling orchestrator

  2002cited by this paper
• The urokinase receptor mediates basic fibroblast growth factor-dependent smooth muscle cell migration through baboon aortic explants.

  2002cited by this paper
• EGF family ligand-dependent phenotypic modulation of smooth muscle cells through EGF receptor.

  2001cited by this paper
• Mechanisms of Neointima Formation and Remodeling in the Porcine Coronary Artery

  2001cited by this paper
• Rac Mediates Cytoskeletal Rearrangements and Increased Cell Motility Induced by Urokinase-Type Plasminogen Activator Receptor Binding to Vitronectin

  2001cited by this paper
• Adenoviral Expression of a Urokinase Receptor–Targeted Protease Inhibitor Inhibits Neointima Formation in Murine and Human Blood Vessels

  2001cited by this paper
• Expression of the plasminogen activator system in the human vascular wall.

  2000cited by this paper
• Atherosclerosis : Vascular biology

  2000cited by this paper
• Native Atherosclerosis and Vein Graft Arterialization: Association with Increased Urokinase Receptor Expression In Vitro and In Vivo

  1998cited by this paper
• Augmented urokinase receptor expression in atheroma.

  1995cited by this paper
• Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro.

  1995cited by this paper
• Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.

  1990cited by this paper

• Rosuvastatin activates autophagy via inhibition of the Akt/mTOR axis in vascular smooth muscle cells

  2024cites this paper
• Simulated in vitro hypoxic conditions from psoriatic arthritis cartilage change plasminogen activating system urokinase and serpine functionality. Reversal of antiapoptotic protection suggests common homeostatic buffering

  2022cites this paper
• Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer

  2020cites this paper
• TPO-Ab plays a role in arterial remodeling in patients with intracranial stenosis.

  2019cites this paper
• α2B-ADRENOCEPTORS IN THE REGULATION OF VASCULAR SMOOTH MUSCLE CELL CONTRACTION AND PROLIFERATION

  2017cites this paper
• An overview of potential molecular mechanisms involved in VSMC phenotypic modulation

  2016cites this paper
• Role of microRNA-21 in the regulation of human saphenous vein smooth muscle cell function and vascular remodelling.

  2016cites this paper
• CHK1 and RAD51 activation after DNA damage is regulated via urokinase receptor/TLR4 signaling

  2016cites this paper
• The Role of Vascular Smooth Muscle Phenotype in Coronary Artery Disease

  2016cites this paper
• Rosuvastatin Inhibits Vascular Smooth Muscle Cell Inflammation Pathways through Promotion of MiR-146a Expression

  2015cites this paper
• Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice

  2015cites this paper
• Effets à long terme de l'atorvastatine à faible dose sur l'athérosclérose : une étude pluridisciplinaire chez un modèle animal, le lapin Watanabe

  2015cites this paper
• Urokinase Receptor Mediates Osteogenic Differentiation of Mesenchymal Stem Cells and Vascular Calcification via the Complement C5a Receptor

  2014cites this paper
• The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?

  2013cites this paper
• Urokinase Receptor Counteracts Vascular Smooth Muscle Cell Functional Changes Induced by Surface Topography

  2013cites this paper
• Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathway.

  2013cites this paper
• Urokinase receptor surface expression regulates monocyte migration and is associated with accelerated atherosclerosis.

  2012cites this paper
• Name of two Co-supervisors ( from different departments )

  2012cites this paper
• Statines et plaque

  2012cites this paper
• Urokinase Receptor Associates With Myocardin to Control Vascular Smooth Muscle Cells Phenotype in Vascular Disease

  2012cites this paper
• Atorvastatin suppresses inflammatory response induced by oxLDL through inhibition of ERK phosphorylation, IκBα degradation, and COX‐2 expression in murine macrophages

  2012influential citation
• LDL-Induced Impairment of Human Vascular Smooth Muscle Cells Repair Function Is Reversed by HMG-CoA Reductase Inhibition

  2012cites this paper
• Basic fibroblast growth factor gene transfection in repair of internal carotid artery aneurysm wall

  2012cites this paper
• N-3 long-chain polyunsaturated fatty acids inhibit smooth muscle cell migration by modulating urokinase plasminogen activator receptor through MEK/ERK-dependent and -independent mechanisms.

  2012cites this paper
• Pleiotropic effects of pitavastatin

  2011cites this paper
• The urokinase receptor in the central nervous system.

  2011cites this paper
• Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells.

  2011cites this paper
• Urokinase plasminogen activator regulates pulmonary arterial contractility and vascular permeability in mice.

  2011cites this paper
• Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats.

  2011cites this paper
• Effects of Combined Therapy with Ezetimibe Plus Simvastatin After Drug-Eluting Stent Implantation in a Porcine Coronary Restenosis Model

  2010cites this paper
• Vascular smooth muscle cell remodelling in elastase-induced aortic aneurysm

  2010cites this paper
• Rosuvastatin reduces neointima formation in a rat model of balloon injury

  2010cites this paper
• In-vivo assessment of the natural history of coronary atherosclerosis: vascular remodeling and endothelial shear stress determine the complexity of atherosclerotic disease progression

  2010cites this paper
• Enhanced effect of losartan and rosuvastatin on neointima hyperplasia

  2010cites this paper
• Interstitial Cells of Blood Vessels

  2010cites this paper
• Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.

  2009influential citation
• Development of an optimized protocol for primary culture of smooth muscle cells from rat thoracic aortas

  2009cites this paper
• Targeting the airway smooth muscle for asthma treatment.

  2009cites this paper
• The tight junction protein ZO-2 mediates proliferation of vascular smooth muscle cells via regulation of Stat1.

  2009cites this paper
• Arterial smooth muscle cells dysfunction in hyperglycaemia and hyperglycaemia associated with hyperlipidaemia: from causes to effects

  2008influential citation
• "Linking proteolysis to lipids".

  2008cites this paper
• An Overview of the Extra-Lipid Effects of Rosuvastatin

  2008cites this paper
• Lighting up cancer aggressiveness: targeting the urokinase plasminogen activator receptor for intraoperative optical imaging

  year unknowncites this paper